Related Experiment Video
Updated: May 31, 2026
08:31
A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Mitral valve repair versus replacement in the elderly population
Sheraz R Markar1, Umar Sadat, Lynn Edmonds
1Department of Cardiothoracic Surgery, Papworth Hospital, Cambridge, UK.
The Journal of Heart Valve Disease
|July 1, 2011
Summary
Mitral valve repair (MVRep) offers better outcomes than mitral valve replacement (MVR) in elderly patients, showing reduced mortality and complications. This suggests MVRep should be the primary treatment for mitral valve disease.
Area of Science:
- Cardiovascular Surgery
- Geriatric Medicine
- Medical Interventions
Background:
- Elderly patients with mitral valve disease face treatment decisions between mitral valve repair (MVRep) and mitral valve replacement (MVR).
- Comparative effectiveness of MVRep versus MVR in this demographic requires thorough evaluation.
Purpose of the Study:
- To conduct a pooled analysis of existing literature comparing MVRep and MVR specifically in the elderly population.
- To determine the optimal surgical approach for mitral valve pathology in older adults.
Main Methods:
- A systematic literature search was performed across major databases (Medline, Embase, Cochrane) and trial registries.
- Four relevant studies were included, analyzing 30-day mortality, postoperative complications, and hospital stay duration.
- Pooled odds ratios and weighted mean differences were calculated for outcome analysis.
Main Results:
- Mitral valve repair (MVRep) demonstrated significantly reduced 30-day mortality (OR = 3.97; p = 0.003) compared to MVR.
- Postoperative complications were also significantly lower following MVRep (OR = 2.35; p = 0.003).
- No significant difference in length of hospital stay was observed between the two procedures (WMD = 0.22; p = 0.18).
Conclusions:
- Mitral valve repair (MVRep) presents clear advantages over mitral valve replacement (MVR) in the elderly, including lower mortality and fewer complications.
- Given these benefits, a randomized trial comparing the two techniques in the elderly is not ethically warranted.
- MVRep is recommended as the primary treatment for mitral valve pathology, regardless of patient age.
Related Concept Videos
01:26Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
01:25Mitral Regurgitation III: Medical Management
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
01:22Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
01:19Mitral Valve Prolapse III: Nursing Management
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
01:28Mitral Regurgitation IV: Nursing Management
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
01:27Mitral Valve Prolapse I: Introduction
IntroductionThe mitral valve, one of the heart's four valves, regulates blood flow. These valves have flaps that open and close to direct blood properly through the heart and body. During each heartbeat, the flaps open for blood to pass through and seal shut to prevent backflow. Specifically, the mitral valve opens to allow blood flow from the heart's upper left chamber to the lower left chamber. It then closes securely as the lower left chamber contracts to pump blood to the body, preventing...